The GABA-B receptor agonist baclofen helps patients with alcohol use disorder: why these findings matter

被引:7
|
作者
Leggio, Lorenzo [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Litten, Raye Z. [9 ]
机构
[1] NIDA, Clin Psychoneuroendocrinol & Neuropsychopharmacol, Translat Addict Med Branch, NIH, Baltimore, MD 21224 USA
[2] NIDA, Clin Psychoneuroendocrinol & Neuropsychopharmacol, Translat Addict Med Branch, NIH, Bethesda, MD 20892 USA
[3] NIAAA, NIH, Baltimore, MD USA
[4] NIAAA, NIH, Bethesda, MD 20892 USA
[5] NIDA, Medicat Dev Program, Intramural Res Program, NIH, Baltimore, MD 21224 USA
[6] Brown Univ, Ctr Alcohol & Addict Studies, Dept Behav & Social Sci, Sch Publ Hlth, Providence, RI 02912 USA
[7] Johns Hopkins Univ, Sch Med, Dept Med, Div Addict Med, Baltimore, MD 21205 USA
[8] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA
[9] NIAAA, Div Treatment & Recovery, Bethesda, MD USA
关键词
DOUBLE-BLIND; SAFETY;
D O I
10.1038/s41386-021-01142-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
[No abstract available]
引用
收藏
页码:2228 / 2229
页数:2
相关论文
共 50 条